References
- Wittenborn JS, Rein DB. Cost of Vision Problems: The Economic Burden of Vision Loss and Eye Disorders in the United States. Chicago: NORC at the University of Chicago; 2013. 6/11/2013.
- The Eye Diseases Prevalence Research Group. Causes and prevalence of visual impairment among adults in the United States. Arch. Ophthalmol. 2004;122(4):477–485. doi:10.1001/archopht.122.4.477.
- Day S, Acquah K, Lee P, Mruthyunjaya P, Sloan FA. Medicare costs for neovascular age-related macular degeneration, 1994–2007. Am J Ophthalmol. 2011;152(6):1014–1020. doi:10.1016/j.ajo.2011.05.008.
- Qualls LG, Hammill BG, Wang F, et al. Costs of newly diagnosed neovascular age-related macular degeneration among medicare beneficiaries, 2004–2008. Retina. 2013 Apr;33(4):854–861. doi:10.1097/IAE.0b013e31826f065e.
- Tan H, Xie L, Wang Y, Yuce H, Baser O. Examine the Burden of Illness of US Medicare Patients Diagnosed with Cataract. Value Health. 2016;19(3):A123–A124. 05/01 2016. doi:10.1016/j.jval.2016.03.501.
- Schmier JK, Covert DW, Lau EC, Matthews GP. Medicare expenditures associated with diabetes and diabetic retinopathy. Retina. 2009 Feb;29(2):199–206. doi:10.1097/IAE.0b013e3181884f2d.
- Schmier JK, Covert DW, Lau EC, Robin AL. Trends in annual medicare expenditures for glaucoma surgical procedures from 1997 to 2006. Arch Ophthalmol. 2009 Jul;127(7):900–905. doi:10.1001/archophthalmol.2009.122.
- Quigley H, Cassard S, Gower E, Ramulu P, Jampel H, Friedman D. The cost of glaucoma care provided to medicare beneficiaries from 2002 to 2009. Ophthalmology. 2013;120(11):2249–2257. 06/11 2013. doi:10.1016/j.ophtha.2013.04.027.
- Newman-Casey PA, Woodward MA, Niziol LM, Lee PP, De Lott LB. Brand medications and medicare part D: how eye care providers’ prescribing patterns influence costs. Ophthalmology. 2018 Mar;125(3):332–339. doi:10.1016/j.ophtha.2017.05.024.
- Rein DB, Zhang P, Wirth KE, et al. The economic burden of major adult visual disorders in the United States. Arch Ophthalmol. 2006;124(12):1754–1760. doi:10.1001/archopht.124.12.1754.
- Keohane LM, Gambrel RJ, Freed SS, Stevenson D, Buntin MB. Understanding trends in medicare spending, 2007–2014. Health Serv Res. 2018 Oct;53(5):3507–3527. doi:10.1111/1475-6773.12845.
- Foundation KF. Medicare advantage fact sheet. 2019; https://www.kff.org/medicare/fact-sheet/medicare-advantage/ Accessed October 25, 2020
- CDC. Vision and Eye Health Surveillance System (VEHSS). 2020; https://www.cdc.gov/visionhealth/vehss/index.html. Accessed August 1, 2020.
- MEDPAC Medicare Payment Advisory Commission, Health Care Spending and the Medicare Program, July 2020 Data Book:4–5. http://www.medpac.gov/docs/default-source/data-book/july2020_databook_entirereport_sec.pdf?sfvrsn=0.
- Data Analysis Brief. Managed Care Enrollment Trends among Dually Eligible and Medicare-only Beneficiaries, 2006 through 2018. In: Office CM-MC, ed Revised May 2020.
- Morse AR, Seiple W, Talwar N, Lee PP, Stein JD. Association of vision loss with hospital use and costs among older adults. JAMA Ophthalmol. 2019 Jun 1;137(6):634–640. doi:10.1001/jamaophthalmol.2019.0446.
- Javitt JC, Zhou Z, Willke RJ. Association between vision loss and higher medical care costs in medicare beneficiaries costs are greater for those with progressive vision loss. Ophthalmology. 2007 Feb;114(2):238–245. doi:10.1016/j.ophtha.2006.07.054.